Skip to main content
. 2024 Jun 3;13(2):e002654. doi: 10.1136/bmjoq-2023-002654

Table 2.

Reliable Diagnosis Challenges taxonomy (total count)

Category GPT Human P value
Challenging disease presentation
 Atypical presentation 513 (94.1%) 211 (38.7%) <0.001
 Non-specific symptoms and signs 82 (15.0%) 69 (12.7%) 0.25
 Unfamiliar/outside specialty 161 (29.5%) 61 (11.2%) <0.001
 Findings masking/mimicking another diagnosis 383 (70.3%) 210 (38.5%) <0.001
 Red herring misleading findings 83 (15.2%) 91 (16.7%) 0.51
 Rapidly progressive course 6 (1.1%) 21 (3.9%) 0.003
 Slowly evolving blunting onset perception 54 (9.9%) 39 (7.2%) 0.10
 Deceptively benign course 24 (4.4%) 8 (1.5%) 0.004
Patient factors
 Language/communication barriers 9 (1.7%) 14 (2.6%) 0.29
 Signal: noise - patients with multiple other symptoms or diagnoses 24 (4.4%) 23 (4.2%) 0.88
 Failure to share data (to be forthcoming with symptoms or their severity) 79 (14.5%) 10 (1.8%) <0.001
 Failure to follow-up 64 (11.7%) 4 (0.7%) <0.001
Testing challenges
 Test not available due to geography, access, cost 58 (10.6%) 5 (0.9%) <0.001
 Logistical issues in scheduling, performing 31 (5.7%) 2 (0.4%) <0.001
 False positive/negative test limitations 54 (9.9%) 38 (7.0%) 0.08
 Performance/interpretation failures 444 (81.5%) 145 (26.6%) <0.001
 Equivocal results/interpretation 99 (18.2%) 44 (8.1%) <0.001
 Test follow-up issues (eg, tracking pending results) 39 (7.2%) 5 (0.9%) <0.001
Stressors
 Time constraints for clinicians and patients 32 (5.9%) 2 (0.4%) <0.001
 Discontinuities of care 137 (25.1%) 1 (0.2%) <0.001
 Fragmentation of care 36 (6.6%) 4 (0.7%) <0.001
 Memory reliance/challenges 20 (3.7%) 3 (0.6%) <0.001
Broader challenges
 Recognition of acuity/severity 91 (16.7%) 43 (7.9%) <0.001
 Diagnosis of complications 16 (2.9%) 35 (6.4%) 0.01
 Recognition of failure to respond to therapy 23 (4.2%) 28 (5.1%) 0.47
 Diagnosis of the underlying aetiological cause 44 (8.1%) 149 (27.3%) <0.001
 Recognising misdiagnosis occurrence 77 (14.1%) 85 (15.6%) 0.50
Unclear 0 (0.0%) 3 (0.6%) 0.08